<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0009563'>Dyskeratosis</z:mp> congenita (DC) is an inherited <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> syndrome characterized clinically by the triad of abnormal nails, reticular skin <z:hpo ids='HP_0001000'>pigmentation</z:hpo>, and <z:hpo ids='HP_0002745'>oral leukoplakia</z:hpo>, and is associated with high risk of developing <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Patients have very short germline telomeres, and approximately half have mutations in one of six genes encoding proteins that maintain telomere function </plain></SENT>
<SENT sid="2" pm="."><plain>Accurate diagnosis of DC is critical to ensure proper clinical management, because patients who have DC and <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> do not respond to immunosuppressive therapy and may have increased morbidity and mortality associated with hematopoietic stem cell transplantation </plain></SENT>
</text></document>